spacer
home > ebr
PUBLICATIONS

European Biopharmaceutical Review

 

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.

With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:

Advertising

Simon Caplan

George Briggs

Editorial

Vanessa Kintu

 

 

Connect with us on Twitter: follow @EBRmagazine
   


 


 Click here to view the digital version of EBR   


ebr
 
 
Featured in this issue
Features
Patient-Centric Designs: A Likely Tipping Point for Biosimilar Adoption

George Ions at Owen Mumford Pharmaceutical Services

Recent opportunities have arisen for biosimilar manufacturers to take hold of the pharma market; however, there are a number of challenges they should be aware of if they wish to properly utilise these opportunities
 
Features
Next-Generation Sequencing Where Weve Been and Where Were Headed

Mirna Jarosz at Integrated DNA Technologies

Tracking the progress made through DNA sequencing in treating once uncurable health conditions may help us realise the untapped potential of sequencing.
 

  Alternative Antibody Drug Scaffolds
Antibody Internalisation Assays

With breakthroughs in molecular engineering and antibody humanisation, antibody-based drugs are one of the fastest growing classes of biopharmaceuticals for multiple clinical indications.

spacer


Published quarterly in
January, April,
July, and October



 

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
News and Press Releases

Northway Biotechpharma enters into Development and Manufacturing Agreement with Synklino

Vilnius, Lithuania, and Copenhagen, Denmark – December 18th 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Synklino, a company active in developing a therapeutic protein based therapy as treatment for cytomegalovirus (CMV) infection, announced today that they entered into a Development and Manufacturing Agreement for the recombinant fusion protein SYNx, which Synklino aims to bring into clinical trials.
More info >>

 
White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement